We theoretically report that, with in-plane magnetization, the quantum anomalous Hall effect (QAHE) can be realized in two-dimensional atomic crystal layers with preserved inversion symmetry but broken out-of-plane mirror reflection symmetry. We take the honeycomb lattice as an example, where we find that the low-buckled structure, which makes the system satisfy the symmetric criteria, is crucial to induce QAHE. The topologically nontrivial bulk gap carrying a Chern number of C = ±1 opens in the vicinity of the saddle points M , where the band dispersion exhibits strong anisotropy. We further show that the QAHE with electrically tunable Chern number can be achieved in Bernalstacked multilayer systems, and the applied interlayer potential differences can dramatically decrease the critical magnetization to make the QAHE experimentally feasible.
Cobalt-doped ZnO (Zn 1Ϫx Co x O) thin films were fabricated by reactive magnetron cosputtering. The processing conditions were carefully designed to avoid the occurrence of Co precipitations. The films are c-axis oriented, and the solubility limit of Co in ZnO is less than 17%, determined by x-ray diffraction. X-ray photoemission spectroscopy measurements show Co ions have a chemical valance of 2ϩ. In this paper, hysteresis loops were clearly observed for Zn 1Ϫx Co x O films at room temperature. The coercive field, as well as saturation magnetization per Co atom, decreases with increasing Co content, within the range of 0.07ϽxϽ0.17. Most intriguing, the Zn 1Ϫx Co x O films are nonconductive as x is no more than 17%. Our results clearly demonstrate that ferromagnetism can be realized in Zn 1Ϫx Co x O without carrier incorporation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.